Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Sep 27
Love0

FULL SUPPLEMENT: Targeting Acne Pathogenesis with Topical Therapies

By Chuck Lin No Comments
In this supplement Topical Acne Therapies and Their Pathogenic Targets  We, as dermatologists, are exceedingly lucky.  We can watch our patients improve before our eyes.  In clinical practice, we don't…
Read More
Sep 25
Love0

Application Characteristics and Patient Preference of Triple-Combination vs Layered Topicals for Acne: Split-Face Study

By Chuck Lin No Comments
INTRODUCTIONIn the treatment of acne, therapies that address multiple pathophysiological pathways are recommended for most patients.1 Combination therapies are generally more efficacious; in a meta-analysis of 221 clinical trials of…
Read More
Sep 24
Love0

Hypochlorous Acid: A Blast from the Past

By Chuck Lin No Comments
INTRODUCTIONHypochlorous acid (HOCl) is one of the latest skincare ingredients to gain widespread popularity on social media. Despite newfound interest by some, the use of HOCl is certainly not new;…
Read More
Sep 20
Love0

A Review of the Vitiligo Literature to Standardize Expression of Disease Severity

By Chuck Lin No Comments
INTRODUCTIONThere is a poor understanding at this time as to best- practice in recording outcomes in vitiligo. This is because there is an extremely heterogeneous set of publications with limited…
Read More
Sep 19
Love0

Opt for Methotrexate Before Biologics in the Treatment of Recalcitrant Delayed-Onset Reactions to Dermal Fillers

By Chuck Lin No Comments
To the Editor: We read with interest the case of a post-hyaluronic acid (HA) filler reaction treated with abrocitinib, a JAK inhibitor (JAKi), by Lopez and colleagues.1 The article brings…
Read More
Sep 19
Love0

Reply to “The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers”

By Chuck Lin No Comments
INTRODUCTIONWe read with great interest the Cartwright et al paper "The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers".1 Within dermatology, there is now…
Read More
Sep 17
Love0

Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema

By Chuck Lin No Comments
INTRODUCTIONThe role of the vehicle in topical prescription treatments is to deliver therapeutic concentrations of an active drug to a designated skin target site to support patient adherence and satisfaction,…
Read More
Sep 17
Love0

Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is one of the most prevalent inflammatory skin conditions, characterized by recurrent eczema with varying degrees of erythema, pruritus, xerosis, and pain. Pruritus is a cardinal indicator…
Read More
Sep 16
Love0

The ABCs of JAKis: A Clinician’s Guide to Safety and Monitoring of the Systemic JAK Inhibitors

By Chuck Lin No Comments
INTRODUCTIONSince the release of the first FDA-approved targeted biologic agent in 2017, several years have elapsed since a new systemic therapy has been approved for atopic dermatitis (AD). Now, however,…
Read More
Sep 13
Love0

Treatment of Granuloma Annulare Using Tapinarof Cream 1%

By Chuck Lin No Comments
INTRODUCTIONGranuloma annulare (GA) is a benign, non-infectious cutaneous granulomatous disease with an estimated prevalence of up to 0.06% in the United States.1 It typically presents as skin colored to erythematous…
Read More
Sep 11
Love0

A Brief Report of 13 Cases of Poppers Dermatitis

By Chuck Lin No Comments
INTRODUCTIONPoppers are psychoactive inhalants commonly employed in the gay male community for their ability to relax anal sphincter muscles.1 These drugs induce numerous adverse effects including dizziness, retinal degeneration, headache,…
Read More
Sep 10
Love0

Topical Treatment of Atopic Dermatitis: An Adherence-Based Appraisal of the AAD Guidelines

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) places a financial and illness burden on children and adults and is the most common chronic inflammatory skin disease.1 In July of 2023, the American Academy of…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis February 25, 2026
  • Impact of TNF-α and IL-17 Biologics on Cardiometabolic Outcomes in Hidradenitis Suppurativa: Retrospective Cohort Study February 25, 2026
  • Author Spotlight: David Ciocon MD February 23, 2026
  • Non-Invasive Diagnosis of Sun Damaged Skin: Actinic Keratosis Vs Squamous Cell Carcinoma February 19, 2026
  • ChatGPT and DeepSeek in Dermatologic Practice: Do Artificial Intelligence Models Adhere to Psoriasis Treatment Guidelines? February 18, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search